At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Non Inferiority Trial for the Study of Acupuncture on Rheumatoid Arthritis
In Brief
A clinical study evaluating methotrexate, non-steroidal anti-inflammatory drug (NSAID), and 2 other interventions for Rheumatoid Arthritis. Completed, enrolled 10 participants across 1 site.
Detailed Summary
Acupuncture is used and recommended by the WHO for the treatment of Rheumatoid Arthritis. The molecular bases of this recommendation are not known, the investigators want to compare with the usage of high-throughput molecular technologies the variations occurring in patients treated with acupuncture and conventional treatment with the ones treated with conventional treatment only. The investigators observe the variations in blood and in the gut microbiome.
Study Details
Timeline
Interventions
methotrexate: 7.5mg/week to 15mg/week for 3 months
NSAID: 100mg twice a day for 3 months
leflunomide: 20mg/day for 3 months
methotrexate: 7.5mg/week to 15mg/week for 3 months
NSAID: 100mg twice a day for 3 months
leflunomide: 20mg/day for 3 months
30 minutes acupuncture every other day for 3 months. Basic acupoints: Zusanli, st36; Taixi,KI3); Shenxu, BL23 Additional acupoints due to personal condition: Waiguan,SJ5; Baxie,Ex-UE9;Yinlingquan,(SP9); Quchi,LI11; Yanglingquan,GB34; Xuehai,SP10; Dazhu,BL11; Dazhui,DU14; Pixu,BL20.